Michael HeltzenShekhar NatarajanTomorrow TodayBio technologyCRISPRGenomicsMolecular Biology

AI, Enzymes and the Future of Medicine | Michael Heltzen x Shekhar Natarajan

Episode 44Nov 4, 2026
In this conversation
Michael Heltzen
Michael Heltzen
Michael Heltzen is a prominent tech entrepreneur, corporate strategist, and investor

How could artificial intelligence and biotechnology reshape our understanding of life, medicine, and the future of humanity? As science continues to advance, the possibilities of combining biology with intelligent technology are opening new doors to discovery and innovation.

In this episode of Tomorrow, Today, host Shekhar Natarajan sits down with Michael Heltzen to explore the fascinating intersection of biology, artificial intelligence, entrepreneurship, and emerging technologies.

Michael reflects on his unconventional journey from day trading to bioinformatics, sharing how his interest in technology evolved into exploring the complexities of biological systems. The conversation dives into the world of DNA sequencing, genomic research, CRISPR, molecular biosensors, and graphene-based technologies—and how these innovations are helping scientists explore new ways to understand and interact with life.

The discussion also looks at how AI could accelerate scientific research, influence drug discovery, and create new possibilities in medicine and biotechnology. From programmable biology to human longevity, Michael and Shekhar examine the opportunities ahead while considering the ethical questions surrounding powerful technologies.

As artificial intelligence becomes increasingly integrated into our lives, they also reflect on the importance of responsible innovation, human values, and the skills that technology cannot easily replace. Empathy, curiosity, collaboration, communication, and meaningful human connection remain essential in shaping a future where technology serves humanity.

This episode offers a thought-provoking look at how biology and AI are converging—and what that could mean for science, business, healthcare, and the next generation of innovation.

shekhar-signature-

Copyright 2026. Shekhar Natarajan

Innovation and Supply Chain Case Studies